Latest Breaking News On - Company or biocartis - Page 1 : comparemela.com

Press release Biocartis Group NV: Four Abstracts Showing

PRESS RELEASE 20 October 2023, 07:00 CEST Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress.

Region flamandeComunidad autonoma de catalunaUnited statesUnited kingdomArndt hartmann erlangenSergi clavRoger moodyErnest nadal lhospitaletLee robertson birminghamBiocartis idylla genefusionGenefusion panelCompany or biocartisEuropean society of molecular oncologyExchange commissionNeither the companyBiocartis group

Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla Presented at European Society of Molecular Oncology Congress (ESMO)

Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla Presented at European Society of Molecular Oncology Congress (ESMO)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomComunidad autonoma de catalunaRegion flamandeRoger moodyIndiens wirtschaftIdylla genefusionSergi clavArndt hartmann erlangenIhre chancenErnest nadal lhospitaletLee robertson birminghamBiocartis idylla genefusionCompany or biocartisEuropean society of molecular oncologyNeither the company

Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio -October 16, 2023 at 01:02 am EDT

PRESS RELEASE 16 October 2023, 7:00 CEST Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio Mechelen, Belgium, 16 October 2023 – Biocartis Group NV , an.

Region flamandeUnited statesBiocartis idyllaRoger moodyDegraders serdsInternational breast cancer study group trialsNeither the companyBiocartis groupCompany or biocartisExchange commissionAmerican cancer societyClinical cancer researchGallen international breast cancer conferenceHonors breast cancer awareness monthBreast cancerBreast cancer portfolio

Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit -October 12, 2023 at 01:01 am EDT

PRESS RELEASE 12 October 2023, 7:00 CEST Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit Mechelen, Belgium, 12 October.

United statesRegion flamandeUnited kingdomCian kavanaghRoger moodyDegraders serdsAssay technologies ltdInternational breast cancer study group trialsNeither the companyResearch use onlyCompany or biocartisExchange commissionBiocartis groupAnnounces expansionChief executive officerCancer subtyping kit

Press Release Biocartis Group NV: Disclosure of transparency notification

PRESS RELEASE: REGULATED INFORMATION 3 October 2023, 7:00 CEST Disclosure of transparency notification Mechelen, Belgium, 3 October 2023 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), announces today, in accordance with Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on the disclosure of major shareholdings in issuers of which shares are admitted to trading on a regulated market and laying down miscellaneous p

New jerseyUnited statesNew brunswickRegion flamandeJohnson plazaJjdc incKenvue incCompany or biocartisBiocartis groupJjdc inc newBelgian financial servicesEuronext brusselsBelgian actJohnson innovationStone johnsonBelgian transparency act